Author Archives: Rebekah Rollston, Brian Clear, and Kelly J. Clark

About Rebekah Rollston, Brian Clear, and Kelly J. Clark

Kelly J. Clark, MD, MBA, DFAPA, DFASAM is the Founder and President of Addiction Crisis Solutions, a company focused on transforming addiction care into evidence-based, cost-effective practice. Dr. Clark serves as Immediate Past President of ASAM, representing over 6,200 addiction physician specialists and allied health professionals, and the Steering Committee of NAM’s Action Collaborative on the US Opioid Epidemic as Co-Leader of the Research, Data, and Metrics Working Group. Dr. Clark is a Director of DisposeRX, the leading solution in site of use drug disposal, and is a consultant to Path healthcare and Bicycle Health. She is currently a member of the Milken Institute Center for Public Health Advisory Group. She has provided her expertise to the US Presidential Opioid Commission, FDA, SAMHSA, the Office of Comptroller General; the Pew Trusts, National Safety Council, and National Business Group on Health; and numerous provider and payer organizations.

Treating the Opioid Crisis: Current Trends and What’s Next, Part 2

By | February 17, 2021
0 Comment

Last week, we discussed three noteworthy trends from the past decade in treating the opioid crisis. The first was recognizing medication for opioid use disorder (MOUD) as the standard of care. The second was formalizing an addiction medicine specialty. And the third was expanding the availability of MOUD. This week, we’ll consider three additional trends in… Read More »

Treating the Opioid Crisis: Current Trends and What’s Next

By | February 11, 2021
0 Comment

Throughout the past decade, the U.S. has seen a dramatic shift in addiction medicine research, clinical practice, and related stigma in seeking care. In a pair of blog posts, we will explore the top six trends related to treating the opioid crisis. And we’ll consider what may be next. The Opioid Epidemic Opioid addiction has… Read More »